Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beijing Health Guard Biotechnology Days Payable?
Beijing Health Guard BiotechnologyBJSE:920575 47 Days Payable is 3,164,054.64 as of Jun. 2026, which is 706% above its 10-year median of 392,734.93. GuruFocus rates BJSE:920575 with a GF Score™ of 47/100 and a GF Value™ of ¥7.92 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 708 Biotechnology companies, Beijing Health Guard Biotechnology ranks better than 99.72% on this metric.
BJSE:920575'
s Days Payable Range Over the Past 10 Years
Min: 124.96 Med: 392734.93 Max: 2063577.27
Current: 256715.46
During the past 13 years, Beijing Health Guard Biotechnology's highest Days Payable was 2063577.27. The lowest was 124.96. And the median was 392734.93.
BJSE:920575's Days Payable is ranked better than 99.72% of 708
companies
in the Biotechnology industry
Industry Median: 111.165
vs BJSE:920575: 256715.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology Days Payable Chart
BJSE:920575 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Beijing Health Guard Biotechnology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Health Guard Biotechnology Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's Days Payable distribution charts can be found below:
* The bar in red indicates where Beijing Health Guard Biotechnology's Days Payable falls into.
Beijing Health Guard Biotechnology Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology (BJSE:920575) has a Days Payable of 3,164,054.64 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Health Guard Biotechnology and its competitors. This is 706% above median its historical median of 392,734.93. Over the past decade, Beijing Health Guard Biotechnology's Days Payable has ranged from 124.96 to 2,063,577.27. According to the industry distribution chart, Beijing Health Guard Biotechnology ranks #2 out of 708 companies in the Biotechnology industry, placing it in the top 0.3%.
Is Beijing Health Guard Biotechnology's Days Payable too high?
Beijing Health Guard Biotechnology's current Days Payable of 3,164,054.64 is 706% above median its 10-year median of 392,734.93. Over the past 10 years, this metric has ranged from a low of 124.96 to a high of 2,063,577.27. The Biotechnology industry median Days Payable is 111.17. Beijing Health Guard Biotechnology's value of 3,164,054.64 is 2846168.7% above this industry median. Based on the distribution chart, Beijing Health Guard Biotechnology ranks #2 out of 708 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Health Guard Biotechnology has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Health Guard Biotechnology's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Health Guard Biotechnology ranks #2 out of 708 companies for Days Payable. This places Beijing Health Guard Biotechnology in the top 0% of its industry — outperforming the majority of peers. The industry median Days Payable is 111.17. Beijing Health Guard Biotechnology's value of 3,164,054.64 is 2846168.7% above this benchmark. Historically, Beijing Health Guard Biotechnology's own Days Payable has ranged from 124.96 to 2,063,577.27 over the past decade. While the company's 10-year median is 392,734.93 vs. the industry median of 111.17, Beijing Health Guard Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.17, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Health Guard Biotechnology's current Days Payable of 3,164,054.64 is 2846168.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Health Guard Biotechnology and its competitors. For the Biotechnology industry, the median Days Payable is 111.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Health Guard Biotechnology's current Days Payable is 3,164,054.64, which is 706% above median its own 10-year median of 392,734.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health Guard Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology (BJSE:920575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.92, compared to a current price of ¥5.59 — trading 29.4% below its estimated fair value. The current Days Payable is 3,164,054.64, which is 706% above median its 10-year median of 392,734.93 and 2846168.7% above the Biotechnology industry median of 111.17. Beijing Health Guard Biotechnology's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beijing Health Guard Biotechnology (BJSE:920575), the current Days Payable is 3,164,054.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued.
The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92.
GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.
Key valuation signals for BJSE:920575:
Days Payable: 3,164,054.64 (706% above median its 10-year median of 392,734.93)
GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
Industry Position: 2846168.7% above the Biotechnology median (#2 of 708)
No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score
Get the complete analysis for BJSE:920575
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920575 has been successfully added to your 
